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ABSTRACT 
 
 
 
 
 
Effectiveness of Self Care Module on knowledge and attitude regarding prevention of 
Multidrug-Resistant Tuberculosis (MDR-TB) among Tuberculosis (TB) patients at 
selected setting, Chennai. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 Tuberculosis (TB) remains a major global health problem with devastating social 
and economic costs .TB spreads from person to person by the release of droplets 
containing the bacilli (Mycobacterium Tuberculosis) into the air .TB usually affects the 
lungs, but it can also affect other parts of the body such as the brain, kidneys or the spine 
.The most essential drugs used for the treatment of TB (anti-TB drugs) are Isoniazid, 
Rifampicin, Pyrazinamide, Ethambutol and Streptomycin. It is a curable and preventable 
disease and yet it causes significant morbidity and mortality. 
 
         India has the highest TB burden of all the country in the world, accounting for an 
estimated one- fifth TB cases worldwide. It has an estimated prevalence of million TB 
cases, with 2 million new cases occurring each year (World Health Organization, 
2013). Similarly, Multidrug-Resistant Tuberculosis (MDR-TB) detection from 2009 
Aim and objective: To assess the effectiveness of Self Care Module on knowledge and attitude 
regarding prevention of Multidrug-Resistant Tuberculosis (MDR-TB) among Tuberculosis (TB) 
patients. Methodology: A quasi experimental, equivalent control group design was chosen to 
assess the level of knowledge and attitude regarding Self Care Module conducted at selected 
setting, Chennai. 60 Tuberculosis (TB) patients who fulfilled the inclusion criteria were selected as 
samples using non probability purposive sampling technique. Self Care Module consists of lecture 
cum discussion, video show and reinforcement regarding prevention of MDR-TB. The pre and post 
test level of knowledge and attitude was assessed using structured interview schedule and 4 point 
Likert scale respectively. Results: The findings of the study revealed that the comparison of post 
test level of knowledge and attitude scores regarding prevention of MDR-TB between experimental 
and FRQWUROJURXSWKHFDOFXODWHGXQSDLUHG¶W¶YDOXHZDVDQGUHVSHFWLYHO\ZKLFKGHQRWHV
very high statistical significance at p<0.001level. The correlation between the post test level of 
NQRZOHGJH ZLWK DWWLWXGH VFRUH µU¶ YDOXH ZDV  VLJQLILHV PRderate positive correlation .The 
significant level of association was identified between age, gender and educational status with mean 
differed knowledge and  attitude regarding prevention of MDR-TB in the experimental group. 
Conclusion: Hence the Self Care Module developed by the investigator proved to be an effective 
aid in enhancing the knowledge and attitude regarding prevention of MDR-TB among Tuberculosis 
(TB) patients. 
Keywords: prevention of MDR-TB, self care module, Tuberculosis (TB) patients. 
been tripled in 2013 as 3,00,000. Thus the medical professionals are in a situation to 
reduce the morbidity and mortality rate.         
 
           Although adequate knowledge about importance of drug compliance of 
Tuberculosis patients are provided, most of the patients are not aware about the 
consequences of post TB. So the researcher was fervent to develop a module on 
prevention of MDR-TB through Self Care Module, which is a set of instructions with 
components such as respiratory, household and environmental hygiene, diet and 
importance of vaccination for MDR-TB among Tuberculosis patients through education, 
video show and MDR-TB Module. 
 
OBJECTIVE 
       To assess the effectiveness of Self Care Module on knowledge and attitude 
regarding prevention of Multidrug-Resistant Tuberculosis(MDR-TB) among 
Tuberculosis (TB) patients. 
 
METHODOLOGY 
Research Design 
 Quasi experimental, equivalent control group design. 
 
Variables 
Independent Variable 
       Self Care Module 
 
Dependent Variables 
     Knowledge and attitude regarding prevention of MDR-TB among Tuberculosis 
patients 
 
Setting 
       District Tuberculosis Centre, Karayanchavadi, Chennai 
 
Population 
      Target population- All the patients medically diagnosed with Tuberculosis 
confirmed either in their sputum smears/X-ray/scan/biopsy. 
   Accessible population-Patients medically diagnosed with Tuberculosis, who 
fulfilled the inclusive criteria at District Tuberculosis centre, Karayanchavadi, Chennai. 
 
Sampling 
       The patients diagnosed with tuberculosis, who fulfilled the inclusion criteria by 
non probability purposive sampling technique. 
 
Intervention 
      Self Care Module comprised of  
x Lecture cum discussion on MDR-TB (Disease condition and treatment with 
prevention)  
x Video show on preventive measures of MDR-TB 
x Pictorial module on overview of MDR-TB. 
 
Measurements and tool 
      The pre and post test level of knowledge was assessed using structured interview 
schedule. It consists of 20 multiple choice questions and categorized into 2 components 
about the disease condition, treatment and prevention of MDR-TB. 
 
       The pre and post test level of attitude was assessed using 4 point Likert scale 
consisting of 10 statements out of which 5 were positive and 5 negatively worded 
statements 
 
RESULTS 
       The findings of the study revealed that the comparison of post test level of 
knowledge and attitude scores regarding prevention of MDR-TB between experimental 
and control group, the calculated unpaired ¶W¶ YDOXHZDV  and 18.42 respectively 
which denotes very high statistical significance at p<0.001 level. 
 
The correlation between the post test level of knowledge with attitude score was 
calculated using Karl Pearson correlation FRHIILFLHQW ZLWK µU¶ YDOXH RI  VLJQLILHV
moderate positive correlation, indicates when knowledge of Tuberculosis patient 
increases their level of attitude also increases .The significant level of association was 
identified between age, gender and educational status with mean differed knowledge and 
attitude score in the experimental group. 
 
DISCUSSION 
      There was a significant improvement of knowledge and attitude regarding 
prevention of Multidrug-Resistant Tuberculosis (MDR-TB) among Tuberculosis (TB) 
patients in the post test after administration of Self Care Module. Thus Self Care Module 
was an effective education tool in improving the knowledge and attitude of Tuberculosis 
(TB) patients regarding prevention of MDR-TB. 
 
CONCLUSION 
          Researcher concluded that utilization of Self Care Module developed by the 
investigator will help to improve the knowledge and attitude regarding MDR-TB 
prevention in OPD and IPD of various hospital .It enhances the regular compliance of 
medication and prevents from MDR-TB. The findings of the study reveals that there is a 
significant difference in the pre test and post test level of knowledge and attitude 
regarding prevention of MDR-TB among Tuberculosis (TB) patients. This proves that 
the module is more effective and shows that as knowledge increased attitude also 
increased. 
 
IMPLICATIONS 
         The nurse plays a essential role in building the knowledge and attitude on 
preventive aspects. The intervention is cost effective, reliable and can be incorporated by 
the nurses in all the specialized hospitals in preventing MDR-TB. The study enables the 
nurse educator to incorporate the findings in nursing curriculum with evidence based 
practice. A nurse administrator can organize the training programme for the caregivers 
and other patients with TB for reducing the disease burden. The findings of the study can 
be disseminated through conferences, seminars and by publishing in journals. 
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INTRODUCTION 
 
       7KH VLQJOH ELJJHVW WKUHDW WR PDQ¶V FRQWLQXHG GRPLQDQFH RQ WKH SODQHW LV WKH
micro-organisms (Joshua Lederberg). India is undergoing a epidemiologic, 
demographic and health transition. At present communicable or infectious disease is the 
leading cause of illness and death. Infectious diseases are caused by pathogenic micro-
organisms, such as bacteria, viruses, parasites or fungi; it can be spread from one person 
to another directly or indirectly (World Health Organization (WHO), 2006).Globally 
there are 13 notifiable communicable diseases, amongst Tuberculosis is the leading 
cause of death. 
 
       Tuberculosis (TB) remains a major global health problem with devastating social 
and economic costs. TB spreads from person to person by the release of droplets 
containing the bacilli (Mycobacterium Tuberculosis) into the air. TB usually affects the 
lungs, but it can also affect other parts of the body such as the brain , kidneys or the spine 
.The most essential drugs used for the treatment of TB (anti-TB drugs) are Isoniazid, 
Rifampicin, Pyrazinamide, Ethambutol and Streptomycin. It is a curable and preventable 
disease and yet it causes significant morbidity and mortality. 
 
        In some extent, use of anti-TB drugs, has contributed significantly to the 
emergence of Drug-Resistant TB in India .Depending upon the number of drugs to which 
bacilli are resistant ,various types of TB are originated such as :Mono Drug Resistant 
TB, Poly Drug Resistant TB, Multidrug-Resistant TB (MDR-TB) and Extensively Drug 
Resistant TB. Drug resistance arises due to irregular and incomplete treatment, poor 
treatment management, non-availability of certain drugs and no monitoring of treatment. 
 
        MDR-TB is a specific form of drug resistant TB due to bacilli resistant to at least 
Isoniazid and Rifampicin, with or without resistance to any other anti-TB drugs .The 
person may be infected with a Tubercle strain that is already drug-resistant .This is 
termed as primary drug resistance .The Multidrug Resistance develops while the person 
is receiving drug therapy, the resistance is called acquired drug resistance. 
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      ,QERWKWKHFDVHVWKHSDWLHQWZKR¶VQRWUHFHLYLQJDVWURQJHQRXJKGRVDJHRIWKH
drugs over a long enough period of time to kill the bacilli, so the organisms are given 
time to develop resistance to one or more of the drugs. 
 
       The diagnosis of MDR-TB in field conditions is a challenge. Because of slow 
growth of M .Tuberculous bacilli it takes a long time to isolate the bacilli on culture .The 
goal of MDR-TB treatment is to prevent the further development and spread of MDR-
TB. A standard treatment is administered for the treatment of MDR-TB patients, into two 
phases which are initial Intensive phase followed by the Continuation phase. The 
regimen comprises of 6 drugs in the intensive phase (6 months) and 4 drugs in the 
Continuation phase (18 months). 
 
       Every year, on 24th March ,the World marks World TB day (WTBD), is 
celebrated to mobilize the political and  social commitment for further progress towards 
eliminating Tuberculosis as a public health burden .This year World TB day 2015 paves 
the theme: ³Reach the 3 million: Reach , Treat ,Cure Everyone with TB and accelerate 
progress towards the bold goal of ending TB by 2035´.The WHO denotes the importance 
of eliminating the access barriers to all recommended Tuberculosis diagnostics and drugs 
,and addresses Tuberculosis and MDR-TB as global health security threats .As there is a 
urgent need to fight against the disease. 
 
1.1 BACKGROUND OF THE STUDY                   
      India has the highest TB burden of all the country in the world, accounting for an 
estimated one-fifth TB cases worldwide. It has an estimated prevalence of million TB 
cases, with 2 million new cases occurring each year. About 280,000 people die from TB 
in India annually. (WHO, 2013) 
  
Table: 1.1.1 Global incidence of Tuberculosis by comparing between India and 
other country (2010-14) 
Year India (in million) 
Other country 
(in million) 
2010 1.98 9.4 
2011 1.6 8.8 
2012 2.3 8.6 
2013 2.1 9 
2014 2.3 9 
      Source: WHO, 2014 
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Table: 1.1.2 Global morbidity and mortality rate of TB and MDR-TB in the year of 
2014 
TB and Co-infection Morbidity Mortality 
Tuberculosis 9.6 million 1.5 million 
TB and HIV 1.2 million 0.4 million 
TB among women 3.2 million 480,000 
TB in children 1.0 million 140,000 
MDR-TB 480,000 190,000 
                                   Source: WHO, 2014 
Table: 1.1.3 Statistics of MDR-TB prevalence among new cases of MDR-TB and 
previously treated TB patients with MDR-TB  
Year 
New cases 
(%) 
Previously treated TB patients 
with MDR-TB 
(%) 
2010 2.1 15 
2011 2.5 18.5 
2012 15.4 25 
2013 3.5 20.5 
2014 20 50 
Source: WHO, 2014 
       
There is tripling in MDR-TB in 2013 detection compared with 2009.Extensively 
drug-Resistant TB (XDR-TB) has been reported by 100 countries in 2013. On average, 
an estimated 9% of people with MDR-TB have XDR-TB. If all notified TB patients (6.1 
million, new and previously treated) had been tested for drug resistance in 2013, an 
estimated 300 000 cases of MDR-TB would have been detected.  
 
       Only 48% of the MDR-TB patients in the 2011 cohort of detected cases were 
successfully treated. 16% died, 24% did not have their treatment outcome documented or 
interrupted treatment, and 12% were not cured despite receiving treatment. 
 
      India's Revised National Tuberculosis Control Programme (RNTCP) has an 
overall goal of providing universal access to quality diagnosis and treatment for all TB 
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patients, with an intermediate goal of successfully treating at least 90 percent of all new 
and at least 85 percent of all previously treated patients. 
 
      Despite these achievements, India's efforts to control TB and MDR TB still suffer 
from too few laboratories, slow diagnostic tools, inadequate management of treatment, 
insufficient supplies of second-line drugs, and shortages of trained personnel. 
 
      RNTCP expects to treat about 1,60,000 MDR-TB and 4,100 XDR-TB cases over 
the next 5 years (2012-2017). Therefore new tools are required by 2025, for enhancing 
the treatment for MDR-TB crisis thereby to provide a quality care. 
 
1.2 SIGNIFICANCE AND NEED FOR THE STUDY 
India has a long and distinguished tradition of research in Tuberculosis and 
MDR-TB. Directly Observed Treatment Short Course (DOTS) is effective in preventing 
the emergence of MDR-TB and reverses the incidence of MDR-TB. So we have to end 
MDR-TB by stopping the TB development and spread. 
 
National Strategic Plan TB India (2012-2017) 
Newer strategies have been developed as a comprehensive National Strategic 
Plan under the 12th Five Year Plan of Government of India (2012) and they have 
identified the thrust areas such as: 
x Strengthening and improving the quality of basic DOTS services 
x Further strengthen and align with health system under National Rural Health 
Mission(NRHM) 
x Deploying improved rapid diagnosis at the field level 
x Expand efforts to engage all care providers 
x Strengthen urban TB Control 
x Expand diagnosis and treatment of drug resistant TB 
x Improve communication and outreach 
x Promote research for development and implementation of improved tools and 
strategies. 
 
 
 
5 
 
The END TB global strategy and targets for Tuberculosis prevention, care and 
control after 2015: 
x Their goal is to end the global Tuberculosis epidemic 
x Vision is to provide a world free of Tuberculosis-zero deaths, disease and 
suffering due to Tuberculosis 
x The components of this strategy are ; 
 Integrated, patient-centered care and prevention 
 Bold policies and supportive  systems 
 Intensified research and innovation(WHO) 
The essential elements of the DOTS-Plus strategy framework for the management of 
multidrug-resistant TB are; 
x Sustained government commitment 
x Accurate, timely diagnosis through quality assured culture and drug susceptibility 
testing 
x Appropriate treatment utilizing second-line drugs under strict supervision 
x Uninterrupted supply of quality assured anti-TB drugs and 
x Standardized recording and reporting system. 
These component addresses that the Multidrug-resistant TB awareness will 
strengthen the existing TB control programme. 
 
         Specific measures are being taken within the Revised National Tuberculosis 
Control Programme (RNTCP) to address the MDR-TB problem through appropriate 
management of patients and strategies to prevent the propagation and dissemination of 
MDR-TB. 
 
         Ascora (2014) conducted a study to drug Resistance in Mycobacterium 
tuberculosis Isolates from Northeastern Sudan conventional and molecular techniques 
with 100 samples, the study showed that drug resistant tuberculosis increased steadily 
and provided potentially valuable information on resistant genes circulating in the 
community.  
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          Berhanu Seyoum, Meaza Demissie, Alemayehu Worku, Shiferaw Bekele,  
Abraham Aseffa (2014) conducted a cross-sectional study aimed at determining the 
prevalence and drug resistance patterns of Mycobacterium tuberculosis among new 
smear positive pulmonary tuberculosis patients visiting TB diagnosis and treatment 
facilities among  357 patients at selected health facilities in eastern Ethiopia. The 
findings reveal that the prevalence of MDRTB is relatively low in the study area and 
hence expanding diagnostic capacity for mycobacterial culture and DST is a vital step in 
this regard.  
 
          Indian researcher with evidence Sasee (2011) suggested that certain data had been 
the contributing factor for developing MDR-TB; they are age group, education, 
occupation, history of smoking and type 2 diabetes. Researcher Issakidis (2010) 
conducted a study and understood that TB with HIV co-infection patients may develop 
MDR-TB due to family caregivers being transverse to maintain mental and physical 
health of those patients by leading into treatment adherence. 
 
           Dhammika Nayoma Magana (2011) the results of experimental studies 
performed with strains resistant to INH, SM or RMP suggested that, in clinical settings, 
there was a strong selection pressure for drug resistance-conferring mutations that cause 
minimal fitness defects. 
 
           Bikram Singh Datta, Ghulam Hassan, Syed Manzoor Kadri, Waseem Qureshi,  
Mustadiq Ahmad Kamili, Hardeep Singh (2010) conducted a study to assess the profile 
of Multidrug-Resistant Tuberculosis (MDR-TB) and Extensively Drug-Resistant 
Tuberculosis (XDR-TB) among 970 cases in tertiary care hospital setting, Kashmir valley 
of India.  The  findings denotes that for effective treatment of MDR-TB and XDR-TB, 
early case detection, improved laboratory facilities, availability of appropriate treatment 
regimens, and financial assistance in resource-limited settings through effective political 
intervention are necessary for better patient adherence and overall cure 
 
       Patient with MDR-TB face the prospect of lengthy and often unpleasant 
treatment as well as the real possibility of premature death. Therefore, counseling and 
emotional support are particularly important much as in any other chronic life-threatening 
illnesses. 
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  Healthcare providers have the responsibility of providing quality patient care to 
achieve MDR-TB control. Effective control of MDR-TB will be possible if all these 
agencies come together and work towards a common goal with complete co-operation.  
 
The researcher had practical experience in the speciality of Medical Surgical 
Nursing, in that view most of the TB patients had lack of knowledge regarding TB and 
MDR-TB. In OPD or IPD stay in hospital the explanation of treatment regimen is must. So 
the researcher prepared a module regarding prevention of MDR-TB. This promotes a 
quality of life for the TB patients. 
 
1.3 STATEMENT OF THE PROBLEM 
      A quasi experimental study to assess the effectiveness of Self Care Module on 
knowledge and attitude regarding prevention of Multidrug-Resistant Tuberculosis (MDR-
TB) among Tuberculosis (TB) patients at selected setting, Chennai. 
 
1.4 OBJECTIVES 
1. To assess and compare the pre and post test level of knowledge and attitude 
regarding prevention of MDR-TB among the experimental and control group. 
2. To assess the effectiveness of Self Care Module on knowledge and attitude regarding 
prevention of MDR-TB between the experimental and control group. 
3. To correlate the post test level of knowledge with attitude score regarding prevention 
of MDR-TB in the experimental and control group. 
4. To associate the selected demographic variables with the mean differed level of 
knowledge and attitude regarding prevention of MDR-TB in the experimental group. 
 
1.5 OPERATIONAL DEFINITIONS 
1.5.1 Effectiveness 
            It refers to the outcome of the Self Care Module on knowledge and attitude 
regarding prevention of Multidrug -Resistant Tuberculosis (MDR-TB) among 
Tuberculosis patients which was assessed using structured interview schedule and 4 
point Likert scale devised by the investigator measured at the 7th day after intervention. 
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1.5.2 Self Care Module 
            It is a set of instruction structured by the investigator for the Tuberculosis patients 
in order to prevent from Multidrug-Resistant Tuberculosis (MDR-TB).The set of 
instructions includes, 
¾ Lecture cum discussion on general information regarding Multidrug- Resistant 
Tuberculosis, its disease condition, treatment and preventive methods using 
power point presentation for 5-7 members in a group with the duration of 20-30 
minutes. 
¾ Video show regarding the preventive measures of MDR-TB for 5-7 members in a 
group for about 15 minutes. 
¾ Reinforcement on overview of MDR-TB through Pictorial booklet to enhance the 
knowledge. 
1.5.3 Knowledge 
         It refers to the level of understanding and information gained through Self Care 
Module by the Tuberculosis patients regarding the prevention of MDR-TB and was 
evaluated by the structured interview schedule developed by the investigator. 
 
1.5.4 Attitude 
        It refers to the level of perception of Tuberculosis patients regarding prevention 
of Multidrug-Resistant Tuberculosis through the utilization of Self Care Module and was 
assessed by the 4 point Likert scale. 
 
1.5.5 Prevention of Multidrug-Resistant Tuberculosis 
        It refers to the process of reducing the chance of MDR-TB occurrence through 
Self Care Module with components such as Hygienic practices-Respiratory 
hygiene/cough etiquette, techniques to wear mask, steps in collecting the sputum and 
hygiene, hand washing technique; Household hygiene; MDR-TB and HIV; MDR-TB 
and Diabetes; Medication; Regular follow up are explained to the TB patients through 
education, video show and reinforce through pictorial booklet. 
 
1.5.6 Tuberculosis patients 
            It refers to the patients who are under 20-70 years of age and medically 
diagnosed with Tuberculosis confirmed either in their sputum smears/X-ray/scan/biopsy 
whereby receiving regular DOTS therapy at District Tuberculosis Centre. 
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1.6 ASSUMPTIONS 
1. Self Care Module may improve the knowledge and provide favourable attitude 
among Tuberculosis patients. 
2. The Tuberculosis patients may have some knowledge and attitude on prevention of 
MDR-TB. 
 
1.7 NULL HYPOTHESES 
NH1:  There is no significant difference in the post test level of knowledge and attitude 
regarding prevention of MDR-TB between the experimental and control group at 
p<0.05 level. 
NH2:  There is no significant relationship between the post test level of knowledge and 
attitude regarding prevention of MDR-TB in the experimental and control group 
at p<0.05 level. 
NH3:  There is no significant association of selected demographic variables with the 
mean difference level of knowledge and attitude regarding prevention of MDR-
TB in the experimental group at p<0.05 level. 
 
1.8 DELIMITATION 
1. The study is delimited to a period of four weeks. 
2. The study is delimited only to the Tuberculosis patients. 
 
1.9 CONCEPTUAL FRAMEWORK 
          A conceptual framework or conceptual model is a set of highly abstract, related 
constructs that broadly explains phenomena of interest, expresses assumptions, and 
reflects a philosophical stance (Nancy Burns and Susan K. Grove, 2009). 
 
            Interaction theories are based on the relationships among persons. Emphasis is 
JLYHQRQWKHSHUVRQ¶VSHUFHSWLRQVVHOIFRQFHSWDQGDELOLW\WRFRPPXQLFDWHDQGSHUIRUP
roles thereby goal is achieved through reciprocal interaction.  
 
In view of explaining and relating various aspects of the phenomena related to the 
interaction between the Nurse Investigator and the Tuberculosis patients regarding 
prevention of MDR-TB, the investigator has adopted on Evelyn Adam Interpersonal 
Relationship Model to conceptualize the study. 
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Evelyn Adams was one of the earliest nurse theorists born in 1929, she had 
focused oQ QXUVH¶V LQGHSHQGHQW FRQWULEXWLRQ WR KHDOWK services and insisted that the 
helping relationship and the system process are important to achieve professional goal.  
         Adam focused on the following component; 
x Interaction 
x Assessment 
x Goal setting 
x Intervention 
x Change in behavior 
 
Interaction 
        Human relationship between the beneficiary and the professional aids the helpee 
to live more satisfactorily. In interaction phase, the nurse investigator and the patient 
together interacted and developed helping relationship. This relationship and systemic 
process helped the nurse investigator to render Self Care Module with less difficulty. 
 
Assessment 
         Assessment is the instrument used in collecting information about the 
beneficiary. This phase refers to the assessment of demographic variables and to find the 
effectiveness of Self Care Module on knowledge and attitude regarding prevention of 
MDR-TB among experimental and control group. Nurse investigator used structured 
interview schedule and 4 point Likert scale to assess the knowledge and attitude. 
 
Goal Setting 
         At the end the investigator and the TB patients strive to achieve changes in 
behavior. In this study the goal is to enhance the knowledge and attitude regarding the 
prevention of MDR-TB. 
 
Intervention 
          It refers to the focus and modes of the professional intervention to bring changes 
LQSDWLHQW¶VEHKDYLRUAccording to this study, this phase refers to the administration of 
Self Care Module which includes education, video show and pictorial booklet by the 
investigator to the Tuberculosis patients. 
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Change in behavior 
          The new behavior is indicated as positive outcome in the attainment of adequate 
knowledge and favourable attitude regarding prevention of MDR-TB. This may be 
reinforced by providing MDR-TB Module. This indicates the satisfaction of the needs. 
           If the need not satisfied, reassessment was done and re-education was given. 
 
CONCLUSION 
           The framework guides the investigator to have a interactive relationship with the 
Tuberculosis patients and promote their knowledge towards prevention of Multidrug-
Resistant Tuberculosis. 
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1.10 OUTLINE OF THE REPORT 
Chapter 1: Deals with the background of the study, significance and need for the study, 
statement of the problem, objectives, operational definitions, null hypotheses, 
assumptions, delimitations and conceptual framework 
Chapter 2: Focuses on critical and scientific review of literature related to the present 
study 
Chapter 3: Enumerates methodology of the study 
Chapter 4: Presents the data analysis and data interpretation 
Chapter 5: Deals with the discussion of the study 
Chapter 6: Gives the summary, conclusion, implications, recommendations and                   
limitations of the study. 
           The study report ends with selected references and appendices. 
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REVIEW OF LITERATURE 
 
SECTION 2.1: CONCEPTS OF REVIEW OF LITERATURE 
This chapter deals with the literature review which determines what is known and 
unknown about a particular concept. According to Barbara Krainovich, (Wood and 
Judith Haher, 2002), the review of literature is considered as a ³systematic and critical 
review of the most important scholarly literature on a particular topic´. In particular 
³Critical review is meant as summarization and evaluation of the ideas and information 
of an article´. It means thinking carefully and clearly and taking into consideration about 
both the strengths and weaknesses of the content under the review. 
.  
               The three main purposes of reviewing the literature is to describe what is 
known already about a topic ,provides background for designing a research study and 
answers questions about clinical practice ,developing new projects and making decisions 
in nursing (Marilyn and Judith, 2011). 
 
The design used in this study was quasi experimental, equivalent control group 
design to find the effectiveness of Self Care Module on knowledge and attitude regarding 
prevention of Multidrug-Resistant Tuberculosis (MDR-TB) among Tuberculosis (TB) 
patients. 
 
SECTION 2.2: SOURCES OF REVIEW OF LITERATURE 
              
             This literature review was entailed through the various sources such as primary: 
from published existing research studies, secondary: from national and international 
journal articles and conference manual and the tertiary sources from Medical Surgical 
Nursing and Community Health Nursing books. The search database is from Google 
Scholar, Cochrane Database of Systematic Reviews, Cumulative Index to Nursing and 
Allied Health (CINAHL) and Pubmed and the keywords used for it was Tuberculosis 
,MDR-TB, prevalence, morbidity, mortality, causes, risk factors, symptoms, diagnosis, 
adverse effects, treatment, treatment outcome, prevention, complications, interventions, 
education, HIV and co-infection, and XDR-TB. As of overall reference, 23 reviews been 
collected from national journals and 40 from international journals. 
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SECTION 2.3: ORGANIZATION OF REVIEW OF LITERATURE 
SECTION 2.3.1: Critical and scientific reviews related to prevalence of MDR-TB 
SECTION 2.3.2: Critical and scientific reviews related to risk factors of MDR-TB                              
SECTION 2.3.3: Critical and scientific reviews related to diagnostic measures of MDR-
TB 
SECTION 2.3.4: Critical and scientific reviews related to treatment for MDR-TB 
SECTION 2.3.5: Critical and scientific reviews related to knowledge and attitude 
regarding prevention of MDR-TB 
 
SECTION 2.3.1: CRITICAL AND SCIENTIFIC REVIEWS RELATED TO 
PREVALENCE OF MDR-TB 
Critical Reviews 
           Researchers (Surendra Sharma, Sanjeev Kumar, Saha, Ninoo George, Arora, 
Deepak Gupta, Urvashi Singh, 2012) conducted a cross-sectional descriptive study to 
assess the prevalence of MDR-TB among Category II pulmonary TB patients and found 
that it was very significant. Many Indian researchers (Kondapaka, KiranKumar, 
Vishnu, 2011; Surapaneni, 2010) conducted studies to assess the proportion of the TB 
patients having MDR-TB at the initiation of retreatment regimen and it was concluded 
that one third of the retreatment pulmonary TB cases are needed of Ethambutol in the 
continuation phase of new TB case treatment in view of high INH resistance.   
 
           Few Indian researchers (Subhakar, et.al, 2010) studied to ascertain the 
prevalence of MDR-TB among new cases of sputum-positive pulmonary TB and 
interpreted that prevalence was low among new cases. 
 
Scientific Reviews 
              Hassan S.O. (2014) conducted a study to Drug Resistance in Mycobacterium 
Tuberculosis Isolates from Northeastern Sudan conventional and molecular techniques 
with 100 samples, the study showed that drug resistant tuberculosis increased steadily 
and provided potentially valuable information on resistant genes circulating in the 
community 
 
           Subhakar Kandi, et al (2013) conducted an analytical, observational, prospective 
cohort study to assess the proportion of the TB patients having MDR-TB at the initiation 
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of retreatment regimen among 100 patients in a tertiary hospital, Hyderabad. The 
findings shows that one third of the retreatment pulmonary TB cases had MDR-TB at the 
initiation of the treatment and recommended that there is a need to include Ethambutol in 
the continuation phase of new TB case treatment in view of high INH resistance. 
 
           Evans Sagwa (2012) conducted the study on the burden of adverse events during 
treatment of drug-resistant tuberculosis in Namibia. The objective of this study was to 
assess the prevalence, profile and outcome of adverse events (AEs) associated with 
treatment of DR-TB and to explore possible influences of HIV disease on the occurrence 
of adverse events. The findings are adverse events of varying severity are common 
during treatment of DR-TB, particularly in the intensive phase of therapy. 
 
           Elisabeth Sanchez, et al (2012) conducted study to measure the prevalence of 
drug resistance TB among 988 patients in Swaziland. The findings assert that the 
prevalence of MDR-TB is more common among previously treated tuberculosis patients 
and they recommend for need of wide-scale intervention in this resource limited area as 
there is lack of health personnel, diagnostic and treatment facilities. 
 
            Deepak Almeida, Camilla Rodrigues,  Zarir F. Udwadia,  Ajit Lalvani, G. D. 
Gothi, Pravin Mehta, (2011) compared the incidence of multidrug resistance in 150 
consecutive Mycobacterium tuberculosis isolates obtained from a rural center (in 
Sakawar, India) and an urban tertiary care center (in Mumbai, India). The study 
highlights an alarmingly high percentage of multidrug-resistant M. tuberculosis isolates 
in Mumbai as compared with that at the rural center. 
 
            Deivanayagam CN, et al, (2010) mounted a study to assess the prevalence and 
pattern of drug resistant pulmonary tuberculosis among treated patients or on those on 
treatment without adequate response and to evaluate HIV seropositivity among MDR-TB 
patients among 1000 Pulmonary TB patients who had at least six months of unsuccessful 
anti-tuberculous treatment. The study revealed that prevalence of MDR-TB was high of 
resistance for reserve drugs (Ethionamide, Kanamycin and/or Ofloxacin) in patients who 
never had these drugs in their earlier treatment schedules suggest the possibility of 
emerging spontaneous drug resistant mutants. 
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SECTION 2.3.2: CRITICAL AND SCIENTIFIC REVIEWS RELATED TO RISK 
FACTORS OF MDR-TB 
Critical Reviews 
           Researcher (Marahatta SB, 2010) in his study updated Multidrug-Resistant 
Tuberculosis burden and risk factors had revealed that prevalence of the drug resistant 
Tuberculosis has risen to the highest rate ever recorded in the history. Few researchers 
(Atre SR, Chatterjee, 2010) applied a study to find the risk factors associated with 
MDR-TB among Category I TB patients and found gender and co-morbid illness are 
important predictors of MDR-TB development. 
 
Scientific Reviews 
            karthickeyan Duraisamy, et al (2014) conducted population based study to 
describe demographic, clinical, and risk characteristics associated with treatment 
outcomes for all patients with Multidrug-Resistant Tuberculosis among 179 patients who 
got registered in the Revised National Tuberculosis Control Programme in Kerala and 
assessed that outcomes among patients consuming alcohol remained poor. 
 
          Bhatt G, Vyas S, Trivedil K (2012) conducted a study to assess the socio 
demographic profile, housing environment, health-seeking behaviour, present and  past 
history regarding treatment of MDR-TB by the cross sectional design among 81 patients 
with the age group of 16-45years.The study was carried out through personal interviews 
using pre-designed, pre-tested proforma and the findings revealed that most of the 
patients perceived some degree of improvement based on their factors following the 
treatment. 
 
          Dennis Falzon (2012) did a descriptive study to assess the Multidrug-resistant 
tuberculosis around the world  with 88% of estimated MDR-TB cases occur in middle- 
or high-income countries, and 60% occur in Brazil, China, India, the Russian Federation 
and South Africa and the findings reveals  that although progress has been noted in the 
expansion of MDR-TB care, urgent efforts are required in order to provide wider access 
to diagnosis and treatment in most countries with the highest burden of MDR-TB. 
 
           Sachin 5 $WUH 'HVLUHH 7% '¶6RX]D, Tina S Vira, Anirvan Chatterjee, 
Nerges F  Mistry (2011) conducted a study to assess the risk factors associated with 
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MDR-TB among Category I new sputum smear-positive cases, at the onset of therapy in 
an case control method among 514 patients in four selected wards of Mumbai. The data 
was collected through semi-structured interviews and drug susceptibility test results and 
the findings denote that these screening tools were useful for diagnostic and treatment 
facilities for MDR-TB. 
 
          Molly F Franke, et al (2011) performed a retrospective study review to identify 
risk factors for default from MDR-TB therapy and conducted home visits to assess 
mortality among patients who defaulted from such therapy with 671 patients and found 
that the proportion of patients who defaulted from MDR TB treatment was relatively low 
and the large proportion of patients who had culture-positive sputum at the time of 
treatment default underscores the public health importance of minimizing treatment 
default. 
 
SECTION 2.3.3: CRITICAL AND SCIENTIFIC REVIEWS RELATED TO 
DIAGNOSTIC MEASURES OF MDR-TB 
          Many researchers (Antonino Catanzaro, Timothy C Rodwell, Donald G 
Catanzaro, Richard S Garfein, Roberta L Jackson, Marva Seifert, 2015) aimed to 
compare the performance of several recently developed assays for detecting multi and 
extensively drug-resistant tuberculosis in a large multinational field trial and evaluated 
that these assays provided the clinicians with timely detection of resistance to the drugs 
tested. Researchers (Ling, Zwerling, Pai, 2010) conducted meta-analysis study to screen 
patients at risk of drug-resistant TB and detected that Genotype MDTBR being an 
excellent accuracy for rifampicin resistance and suggested it as a rapid screening tool. 
 
           Indian researcher (Susan E Dorman, 2011) in her study observed for current 
tools and strategies for diagnosis of MDR-TB are inadequate specifically in settings with 
a high prevalence of HIV infection and denotes that there is a clear need for 
development, introduction and effective implementation of cost-effective new tools that 
contribute to improvement in patient centered outcomes. (Giovanni, Alberto, Daniela, 
Madhukar, 2011) studied current standards and challenges for the diagnosis of MDR-
TB and XDR-TB with FAST Plaque-Response bacteriophage assay, Colorimetric redox 
indicator methods and microcolony method, these diagnostic options effectively 
addressed the threats of  MDR-TB and XDR-TB. 
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            Multiple researchers (Pieter, Robin, Paul,2011; Helden, Murray, Thomas, 
2010) assessed for the rapid diagnosis for controlling Drug-susceptible and DR-TB in 
communities which signifies where they found drug-susceptibility testing being highly 
reliable and sensitive diagnostic tool to find out MDR-TB. 
 
SECTION 2.3.4: CRITICAL AND SCIENTIFIC REVIEWS RELATED TO 
TREATMENT FOR MDR-TB 
Critical Reviews 
         Researchers (Kwok-Chiu, Wing-Wai, Chang, 2012) conducted studies regarding 
management of difficult multidrug-resistant tuberculosis and extensively drug-resistant 
tuberculosis and they observed that preventive strategies include prompt diagnosis, 
DOTS strategy and drug-resistance programmes, also suggested immunotherapy may 
also have a role in the future. 
 
         Multiple researchers (Falzon ., et al, 2010; Blanc., et al, 2011) analysed on the 
production of guidelines for the programmatic management of drug-resistant tuberculosis 
and recommended to support the wider use of rapid drug susceptibility testing for INZ 
and Rifampicin. 
 
Scientific Reviews 
         Anita Rani Kansal , Rajinder Mahal , D. Behera , Neeta Singla (2014) study was 
undertaken to analyse the outcomes of MDR-TB patients treated at the Tuberculosis 
Research Centre, among 600 patients in Chennai and outcomes of this small group of 
MDR-TB patients treated with the RNTCP's STR is encouraging in this setting. Close 
attention needs to be paid to ensure adherence, and to the timely recognition and 
treatment of ADRs    
 
         Ibrahim I Elmahallawy et al (2012) conducted a study to assess treatment 
outcomes among 200 patients with MDR-TB in an retrospective design in Abbassia 
Chest Hospital. The findings revealed that successful treatment could be achieved in 
66% of MDR-TB patients. 
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        Shama D Ahuja, et al (2012) conducted a Meta analysis among 32 patients to 
identify studies reporting the treatment outcomes of microbiologically confirmed MDR-
TB. The findings revealed that the success and the survival rate are improved in MDR-
TB treatment with the use of Fluoroquinolones, Ethionamide or Prothionamide. The 
recommendation is to optimize MDR-TB treatment. 
 
       Evans Sagwa (2012) conducted the study on the burden of adverse events during 
treatment of drug-resistant tuberculosis in Namibia. The objective of this study was to 
assess the prevalence, profile and outcome of adverse events (AEs) associated with 
treatment of DR-TB and to explore possible influences of HIV disease on the occurrence 
of adverse events. The findings are adverse events of varying severity are common 
during treatment of DR-TB, particularly in the intensive phase of therapy. 
 
        Atun RA, Lebcir R, Drobniewski F, Coker RJ (2010) conducted a study to 
determine the impact of an effective programme of Multidrug-Resistant Tuberculosis 
control on a population that is witnessing an explosive HIV epidemic among injecting 
drug users using 2000 patients in Tamil Nadu where the study proves that prevalence of 
MDR-TB is already high as the HIV epidemic matures then the impact of MDRTB 
grows substantially if MDRTB control strategies are ineffective. 
 
SECTION 2.3.5: CRITICAL AND SCIENTIFIC REVIEWS RELATED TO 
KNOWLEDGE AND ATTITUDE REGARDING PREVENTION OF MDR-TB 
Critical Reviews 
          Researchers (Isara, Akpodiete, 2015) conducted cross-sectional study on 
concerning about the knowledge of MDR-TB among health care workers and patients in 
Southern Nigeria, datas were collected using  a structured interviews administered 
TXHVWLRQQDLUHDQGIRXQGWKDWWKHUHZDVODFNRINQRZOHGJHIRUERWK+&:¶VDQGSDWLHQWV
regarding MDR-TB. Indian researchers (kansal Anita Rani,  Mahal Rajinder, Behera, 
Sarin Rohit, 2014) conducted a study to assess learning need, knowledge and  attitude 
of nurses regarding MDR-TB care under RNTCP and evaluated the factors with three 
different tools and found that demographic variables did not affect the attitude score 
except qualification, and need to improve view on XDR-TB. 
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          (Jango Bati, Mengistu Legesse, Girmay Medhin, 2013) did a community-based 
cross sectional study to assess the level of Knowledge, attitude and practices about 
MDR-TB in Itang special district using interviewed pre-tested questionnaire and 
interpreted that majority of the study participants had no correct information about the 
causative factor of MDR-TB and the main symptoms. 
 
         Few researchers (Farley, Tudor, Mphahlele, Franz, Perrin, Dorman, 2012) 
conducted operational evaluations of infection control in drug-resistant TB settings at a 
national level using structured interviews with key informants and demonstrated that 
they need to improve and standardize infection control infrastructure. (Omotayo David, 
Adebanjo, 2011) investigated the knowledge, attitudes and practices of healthcare 
professionals about prevention and control of MDR-TB at Lesotho hospital by means of 
a semi-administered questionnaire. The findings of the study showed that the attitude of 
respondents towards patients suffering from MDR-TB did not influence their practices. 
 
Scientific Reviews 
          Kar M, Logaraj M (2011) conducted a cross-sectional study to assess the 
awareness, attitude and treatment seeking behavior regarding Tuberculosis. Out of 1985 
people, 56% had heard about Tuberculosis but 80% were not aware of the cause and 
mode of spread of Tuberculosis among the people of rural Tamil Nadu. The result shows 
that only 34% of people were aware of the treatment for Tuberculosis as free of cost. 
 
SUMMARY 
          This chapter reveals that the risk factors were been the major component for the 
prevalence of MDR-TB and comparing with various studies indicates that the mortality 
and the morbidity rate of MDR-TB can be reduced by promoting the knowledge through 
various educational resources. 
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RESEARCH METHODOLOGY 
 
            Research Methodology is a research designed to develop or refine methods of 
obtaining, organizing or analyzing date. (Denise .F. Polit and Cheryl. Tatano Beck) 
 
This chapter explains the methodology adopted to assess the effectiveness Self 
Care Module on knowledge and attitude regarding prevention of Multidrug-Resistant 
Tuberculosis (MDR-TB) among Tuberculosis (TB) patients .The phases of the study 
includes research design, variables, setting, population, sample and sample size, criteria 
for sample selection, sampling technique, description of the tool, content validity and 
reliability of the tool, pilot study, data collection procedure and plan for data analysis. 
 
3.1 RESEARCH APPROACH 
               The quantitative research approach was used in this study. 
 
3.2 RESEARCH DESIGN 
               The research design used in this study was quasi experimental, equivalent 
control group design. 
GROUP PRE TEST(O1) 
INTERVENTION (X) 
(On the day of pretest) 
POST TEST(O2) 
(At the end of 7th 
day) 
Experimental 
group 
 
Level of 
knowledge 
and attitude 
regarding 
prevention of 
MDR-TB by 
using 
structured 
interview 
schedule and 
4 point 
Likert scale 
respectively. 
 
 
Self Care Module regarding 
prevention of MDR-TB among 
Tuberculosis patients, 
administered through 
x Education about MDR-TB 
x Video show on preventive 
measures of MDR-TB 
x Reinforcement on overview 
of MDR-TB through 
Pictorial booklet 
 
 
x Level of 
knowledge and 
attitude regarding 
prevention of 
MDR-TB by using 
structured 
interview schedule 
and 4 point Likert 
scale respectively 
 
x Administration 
of 
Self Care  
Module 
Control group 
     
     Followed centre routine 
General information regarding 
TB and its treatment 
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3.3 VARIABLES 
3.3.1 Independent Variable 
      The independent variable in the study was Self Care Module 
 
3.3.2 Dependent Variable 
      The dependent variable in this study was knowledge and attitude regarding 
prevention of MDR-TB among TB patients. 
 
3.3.3 Extraneous Variables 
        Age, gender, education, occupation, type of family, area of residence, family 
history of Tuberculosis and chronicity of disease. 
 
3.4 SETTING OF THE STUDY 
      The study was conducted at District Tuberculosis Centre, Karayanchavadi, 
Chennai. This is a complete Government controlled Primary Health Centre with only 
Outpatient service and they cover 14 rural and semi-urban areas with the population of 
2,800 peoples. The services available are Directly Observed treatment Short Course 
Therapy (Monday to Saturday), Integrated Counseling and Testing Centre (on 
7XHVGD\¶V), lab and microbiology (from Monday to Saturday). Among this the 
treatment population comprises of 130 Pulmonary Tuberculosis patients, 10 Extra 
pulmonary and 5 MDR-TB patients. The hospital routine been followed were general 
education on Acquired Immunodeficiency Syndrome and Tuberculosis with 
complications. 
 
3.5 POPULATION 
3.5.1 Target population 
            All the patients medically diagnosed with Tuberculosis confirmed either in their 
sputum smears/X-ray/scan/biopsy  
 
3.5.2 Accessible population 
           Patients medically diagnosed with Tuberculosis, who fulfilled the inclusive 
criteria at District Tuberculosis Centre, Chennai. 
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3.6 SAMPLE 
          The Tuberculosis patients who fulfilled the inclusion criteria were the samples of 
the study. 
 
3.7 SAMPLE SIZE 
          Sample size comprised of 60 Tuberculosis patients, 30 each in experimental and 
control group who fulfilled the inclusion criteria. 
 
3.8 CRITERIA FOR SAMPLE SELECTION 
3.8.1 Inclusion criteria 
Tuberculosis patients who 
x are willing to participate in the study 
x are in the age group between 20 -70 years 
x can understand English or Tamil 
x is under DOTS therapy 
x are with Pulmonary and Extra-pulmonary Tuberculosis 
x are with co-morbid illness of HIV, Diabetes Mellitus and Cancer only 
 
3.8.2 Exclusion criteria 
Tuberculosis patients who 
x are with visual and hearing impairment and  mentally challenged  
x have attended any programme on prevention of MDR-TB within 6 months 
x are with MDR-TB 
 
3.9 SAMPLING TECHNIQUE 
The patients diagnosed with tuberculosis, who fulfilled the inclusion criteria were 
selected by non probability purposive sampling technique. The patients who received 
DOTS therapy on Monday, Wednesday and Friday were selected as experimental group 
and Tuesday and Thursday patients were in control group. 
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3.9.1 SCHEMATIC REPRESENTATION OF SAMPLING 
 
 
 
 
 
 
 
 
 
            . 
            
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TARGET POPULATION- All the patients medically 
diagnosed with Tuberculosis confirmed either in their sputum 
smears/X-ray/scan/biopsy 
ACCESSIBLE POPULATION- Patients medically diagnosed with 
Tuberculosis, who fulfilled the inclusive criteria at District Tuberculosis 
centre 
SAMPLING TECHNIQUE- 
Non probability purposive 
sampling 
SAMPLE- Patients who 
fulfilled the inclusion criteria 
SAMPLE SIZE- Sample size comprised of 60 
Tuberculosis patients, 30each in experimental and 
control group who is fulfilled the inclusive criteria 
 
DESIGN-Quasi experimental, equivalent control group design 
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3.10 DEVELOPMENT AND DESCRIPTION OF THE TOOL 
            The tool constructed for this study has two parts 
 
3.10.1 Data Collection Tool 
            It consists of three sections 
 
Section A- Demographic variables 
              Demographic variables consisted of age, gender, educational status, 
occupational status, type of family, area of residence, family history of Tuberculosis, 
chronicity of disease, health care resources, personal habits and co-morbid illness. 
 
 Section B-Assessment of knowledge 
             This section consists of structured interview schedule to assess the level of 
knowledge. 
 
             Structured interview schedule which consisted of 20 multiple choice questions 
and categorized into 2 components about the disease condition (meaning, epidemiology, 
risk factors, causes, signs and symptoms, diagnosis, complication) including treatment 
and preventive measures of MDR-TB 
 
Components Questions 
Disease condition 12 
Treatment and prevention 8 
 
Scoring and interpretation  
                   7KH FRUUHFW DQVZHU ZDV JLYHQ µ¶ PDUN DQG ZURQJ DQVZHU ZDV JLYHQ
µ¶PDUN 7KH UDZ VFRUH ZDV converted into percentage to interpret the level of 
knowledge, the level of knowledge was categorized as;             
Score Interpretation 
75-100% Adequate knowledge 
51-74% Moderately adequate knowledge 
50% Inadequate knowledge 
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Section C: Assessment of attitude 
4 point Likert scale consisting of 10 statements was used to assess the attitude 
regarding prevention of MDR-TB among Tuberculosis patients. Out of 10 statements 5 
were positive and 5 negatively worded statements. The raw score was converted into 
percentage to interpret the level of attitude. 
 
Questions 
Strongly 
agree 
Agree 
Strongly 
disagree 
Disagree 
Positive statements 4 3 2 1 
Negative statements 1 2 3 4 
 
Scoring Key 
Percentage Level of attitude 
50% Unfavourable attitude 
51-74% Moderately favourable attitude 
75-100% Favourable attitude 
 
3.10.2 Part b-Intervention tool 
          The intervention was provided as follows; 
x Preliminary Assessment-Demographic variables, Structured interview schedule 
and 4 point Likert scale 
x Group-Tuberculosis patients under 20-70 years of age 
x Venue-District Tuberculosis centre (Waiting hall) 
x Time-8AM to12PM (1 month period of May 2015) 
 
          The intervention tool consisted of, 
x Education- Lecture cum discussion on MDR-TB (The disease condition -
meaning, epidemiology, risk factors, causes, signs and symptoms, diagnosis, 
complication including treatment and preventive measures of MDR-TB) 
x Video show on preventive measures of MDR-TB (Hygienic practices-Respiratory 
hygiene/cough etiquette, techniques to wear mask, steps in collecting the sputum 
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and hygiene, hand washing technique; Household hygiene; MDR-TB and HIV; 
MDR-TB and Diabetes; Medication; Regular follow up) 
x Pictorial Booklet with the overview of MDR-TB (meaning, epidemiology, risk 
factors, causes, signs and symptoms, diagnosis, complication including treatment 
and preventive measures of MDR-TB) 
 
3.11 CONTENT VALIDITY 
             The content validity of the data collection tool and intervention tool was 
obtained from the following field of expertise, 
x Pulmonologist                      - 1 
x Medical Surgical Nursing    - 3 
All the experts had their consensus and then the tool was finalized. 
 
3.12 ETHICAL CONSIDERATION 
            The study was approved by Institution Ethical Review Board (IERB) held on 
December 2014 by International Centre for Collaborative Research (ICCR) 
committee, Omayal Achi College of Nursing. 
 
The investigator considered and followed the principles while proceeding the 
research. 
 
A.BENEFICENCE 
a) The right to freedom from harm and discomfort 
      The study was highly beneficial for the samples (Tuberculosis patients) as it 
enhanced the knowledge and attitude on MDR-TB. 
b) The right to protection from exploitation 
      The investigator explained the procedure and ensured that none of the samples 
would be exploited or denied fair treatment.  
 
B.RESPECT FOR HUMAN DIGNITY 
a) The right to self determination 
      The investigator gave full freedom to the samples to decide voluntarily to 
withdraw from the study and right to ask questions. 
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b) The right to full disclosure 
      The investigator described the nature of the study and obtained oral and written 
consent from the samples and covert data collection had been followed. 
 
C.JUSTICE 
a) The right to fair treatment 
         The investigator selected the study participants based on the research 
requirements, and followed centre routine after the pre test and after the completion of 
post test the intervention was also given for the control group samples. 
 
b) The right to privacy 
        The investigator maintained the samples privacy by following covert entities 
throughout the study. 
 
D.CONFIDENTIALITY 
        The researcher maintained confidentiality in the data provided by the study samples 
with an identification number. 
 
3.13 RELIABILITY OF THE TOOL 
Variable Method Value Inference 
Knowledge 
(Structured interview 
schedule) 
Test-retest 
method 
 
³U´  
 
Highly reliable 
Attitude 
(4 point Likert scale) 
Split half method ³U´  Highly reliable 
 
3.14 PILOT STUDY 
          The pilot study is a trial run preparation for the main study. The pilot study was   
planned and conducted after a research proposal presentation approval by the Ethical 
committee ICCR and nursing experts of Omayal Achi College of Nursing. Setting 
permission had been obtained from the Regional Tuberculosis Officer. Pilot study was 
conducted in the month of May 2015, at District Tuberculosis Centre with 10 
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tuberculosis patients, who fulfilled the inclusive criteria were selected by non-probability 
purposive sampling technique to conduct the pre-experimental study. 
 
            A brief explanation was given regarding the purpose and benefits of the study and 
written consent was obtained from the samples. The data collection was carried out by 
assessing the pre test level of knowledge and attitude using structured interview schedule 
and 4 point Likert scale. Then the investigator administered Self Care Module that is 
education on prevention of MDR-TB through PPT, video show for 45 minutes of about 
5-7 patients in a  group and a Pictorial booklet had been given to overview and reinforce 
about MDR-TB to the Tuberculosis patient. 
 
           The post test was conducted after 7 days. The findings gave the evidence that the 
tool was reliable and practicable to implement in the main study. To prove the 
effectiveness of Self Care Module by comparing the two groups, the pre experimental 
design was changed as quasi-experimental for the main study. 
 
3.15 PROCEDURE FOR DATA COLLECTION  
The main study was conducted after obtaining formal permission from the 
Principal, Omayal Achi College of Nursing. Ethical committee clearance was obtained 
from the International Centre for Collaborative Research (ICCR) and research setting 
permission obtained from the Deputy Director of District Tuberculosis Centre, 
Karayanchavadi, Chennai. 
 
            The investigator selected 60 samples using non probability purposive sampling 
technique from District Tuberculosis Centre, Karayanchavadi, Chennai. The nurse 
investigator met the study samples together in the waiting room and gave introduction 
about self and the study. After giving brief introduction and explanation about the study 
to the samples, the data was collected from each individual. Confidentiality was strictly 
maintained during the process of data collection. 
 
            Tuberculosis patients who are attending OPD on Monday, Wednesday and Friday 
were selected as experimental group and those who are attending Tuesday and Thursday 
were in control group. 
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               The participants were made to sit comfortably in a well ventilated waiting hall. 
First for the experimental group the investigator assessed the pre test level of knowledge 
and attitude using structured interview schedule and 4 point Likert scale respectively.                             
 
            After the pre test the investigator administered Self Care Module on prevention 
of MDR-TB which consists of (the meaning, epidemiology, risk factors, causes, signs 
and symptoms, treatment, complication and preventive measures of MDR-TB), lecture 
cum discussion on MDR-TB including video show on prevention of MDR-TB, and 
distributed Pictorial Booklet regarding MDR-TB to reinforce their level of knowledge 
and attitude. It took about 45 minutes to 1 hour for administering the intervention. 
 
            On the seventh day, the investigator conducted the post test using the same 
structured interview schedule and 4 point Likert scale. Similarly for the control group, 
pre test and the post test was conducted and followed the hospital routine by providing 
information regarding tuberculosis and its treatment. The investigator administered the 
Self Care Module on the 7th day after post test. 
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3.15.1 SCHEMATIC REPRESENTATION FOR DATA COLLECTION 
PROCEDURE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Obtained permission from ICCR and District TB centre, Chennai 
Assess the effectiveness of Self Care Module on knowledge and attitude using 
structured interview schedule and 4 point Likert scale respectively 
Pretest 
Assessment of knowledge and 
attitude using structured 
interview schedule and 4 point 
Likert scale respectively 
Experimental group (n=30) 
(All Monday, Wednesday 
and Friday OPD patients) 
Control group (n=30) 
(All Tuesday and 
Thursday OPD patients) 
Pretest 
Assessment of knowledge and 
attitude using structured 
interview schedule and 4 point 
Likert scale respectively 
Intervention 
Self Care Module 
*PPT on disease condition 
including treatment and 
preventive measures of MDR-TB 
*Video show on preventive 
measures of MDR-TB 
*Pictorial booklet with the 
overview of MDR-TB 
Post test 
(Done on 7th day) 
*Assessment of knowledge 
and attitude 
*Administered Self Care 
Module 
Post test 
(Done on 7th day) 
Assessment of knowledge 
and attitude
Centre Routine-General 
information regarding TB and its 
treatment
Wait list control group 
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3.15 PLAN FOR DATA ANALYSIS 
Data was analyzed by using both descriptive and inferential statistics. 
 
3.16.1 Descriptive Statistics 
1. Frequency and percentage distribution used to analyze the demographic variables 
of the Tuberculosis patients 
2. Mean, standard deviation used to analyze the pre and post level of knowledge and 
attitude among experimental and control group 
 
3.16.2 Inferential Statistics  
1. Paired and unpaired µW¶ WHVW XVHG WR FRPSDUH WKH SUH DQG SRVW WHVW OHYHO RI 
knowledge and attitude regarding prevention of MDR-TB among and between 
the experimental and control group 
2. Correlation co-efficient to find out the relationship between the post test level of 
knowledge and attitude in the experimental group 
3. ANOVA gain score with Chi square test used to associate the selected 
demographic variables with the mean difference level of knowledge and attitude 
score in the experimental group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
34 
 
DATA ANALYSIS AND INTERPRETATION 
 
             Data analysis refers to the process of organizing and synthesizing the data in 
such a way that the research question can be answered and hypothesis tested (Polit and 
Hungler, 2010). 
 
              This chapter deals with the analysis and interpretation of the data to assess the 
effectiveness of Self Care Module on knowledge and attitude regarding prevention of 
Multidrug-Resistant Tuberculosis (MDR-TB) among 60 Tuberculosis (TB) patients at 
selected setting, Chennai. 
 
              The collected data was grouped and analyzed using descriptive and inferential 
statistics, and the results are presented under the following sections. 
 
ORGANIZATION OF THE DATA 
SECTION 4.1: Description of demographic variables of Tuberculosis patients in the 
experimental and control group 
 
SECTION 4.2:  Assessment and comparison of pre and the post test level of 
knowledge and attitude regarding prevention of MDR-TB among the 
experimental and control group           
 
SECTION 4.3:  Effectiveness of Self Care Module on knowledge and attitude 
regarding prevention of MDR -TB between the experimental and 
control group 
 
SECTION 4.4:  Correlation of the post test level of knowledge with attitude score 
regarding prevention of MDR-TB in the experimental and control 
group 
 
SECTION 4.5:  Association of selected demographic variables with the mean differed 
level of knowledge and attitude regarding prevention of MDR-TB in 
the experimental group 
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SECTION 4.1: DESCRIPTION OF DEMOGRAPHIC VARIABLES OF 
TUBERCULOSIS PATIENTS IN EXPERIMENTAL AND CONTROL GROUP 
TABLE 4.1.1: Frequency and percentage distribution of selected demographic 
variables of Tuberculosis patients such as age in years, gender and religion in 
experimental and control group. 
                                                                                                                             N=60  
 
S.No 
 
Demographic variables 
 
Experimental Group 
n=30 
 
Control Group 
n=30 
No % No % 
1. Age in years     
20-29 9 30.0 3 10.0 
30-39 6 20.0 10 33.3 
40-49 7 23.3 6 20.0 
50-59 5 16.7 6 20.0 
60 and above 3 10.0 5 16.7 
2. Gender     
Male 16 53.3 20 66.7 
Female 14 46.7 10 33.3 
3. Religion     
Hindu 24 80.0 27 90.0 
Christian 6 20.0 3 10.0 
Muslim 0 0 0 0 
Others 0 0 0 0 
 
In the experimental group, majority was under the age group of 20-29 years and 
30-39 years in the control group. 
 
In both the group most of them were males and Hindus. 
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Table 4.1.2: Frequency and percentage distribution of selected demographic 
variables of Tuberculosis patients such as marital status, educational status and 
occupation in experimental and control group.  
                                                                                                               N=60 
S.No Demographic variables 
 
Experimental Group 
n=30 
 
Control Group 
n=30 
No. % No. % 
4. Marital status     
Married 22 73.3 25 83.3 
Unmarried 7 23.4 2 6.7 
Widow/Widower 1 3.3 3 10.0 
Divorced 0 0.00 0 0.00 
5. Educational status     
Non Literate 5 16.7 3 10.0 
Primary school certificate 7 23.3 7 23.4 
Middle school certificate 8 26.7 6 20.0 
Higher school certificate 5 16.6 6 20.0 
Intermediate or post high 
school 
2 6.7 4 13.3 
Graduate or Postgraduate 3 10.0 4 13.3 
Professors or Honours 0 0.00 0 0.00 
6. Occupation     
Unemployed    11 36.7 5 16.7 
Unskilled worker 7 23.3 9 30.0 
Semi-skilled worker 4 13.3 6 20.0 
Skilled worker 2 6.7 7 23.3 
Clerical  , shop-owner 2 6.7 1 3.3 
Semi-profession 4 13.3 2 6.7 
Profession 0 0.00 0 0.00 
                   In both the group many were married, in the experimental group most of them had 
completed middle school certificate and were unemployed .Whereas in the control group most 
of them had primary school certificate as well as unskilled worker. 
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Table 4.1.3: Frequency and percentage distribution of selected demographic 
variables of Tuberculosis patients such as family income, type of family, area of 
residence and transmission of TB in experimental and control group.                                                  
N=60  
S.No Demographic variables 
Experimental Group 
n=30 
Control Group 
n=30 
No % No % 
7. Family monthly income(in 
Rupees) 
    
 2 6.7 1 3.3 
1803-5386 12 40.0 10 33.4 
5387-8988 5 16.7 8 26.7 
8989-13494 7 23.3 3 10.0 
13495-17999 2 6.7 6 20.0 
18000-36016 1 3.3 1 3.3 
 1 3.3 1 3.3 
8. Type of family     
Nuclear family 19 63.4 25 83.3 
Joint family 10 33.3 5 16.7 
Extended family 0 0.0 0 0.0 
Separated family 1 3.3 0 0.0 
9. Area of residence                            
Slum 0 0.0 0 0.0 
Rural 0 0.0 0 0.0 
Semi ± urban 30 100.0 30 100.0 
Urban 0 00.0 0 0.0 
10. Transmission of Tuberculosis       
The family 5 16.7 5 16.7 
The workplace 5 16.7 8 26.6 
The neighbours 3 10.0 5 16.7 
Uncertain 17 56.6 12 40.0 
              In both the group, majority of them earns Rs.1803-5386, belonged to a nuclear family, 
residing in a semi-urban area and the transmission of Tuberculosis was uncertain.  
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Table 4.1.4: Frequency and percentage distribution of selected demographic 
variables of Tuberculosis patients such as health care resources, personal habits and 
co-morbid illness in experimental and control group. 
                                                                                          N=60  
S.No Demographic Variables 
Experimental 
Group 
n=30 
Control Group 
n=30 
 
No 
 
% 
 
No 
 
% 
11. Chronicity of disease     
Less than 3 months 8 26.7 8 26.7 
3-6 months 18 60.0 18 60.0 
6 months to 1 year 4 13.3 4 13.3 
12. Healthcare resources     
Hospital 0 0.0 0 0.0 
PHC   30 100.0 30 100.0 
Subcentre   0 0.0 0 0.0 
None 0 0.0 0 0.0 
13. Personal habits- 
Alcohol/substance abuse 
    
 Yes 7 23.3 6 20.0 
No 23 76.7 24 80.0 
14. Co-morbid illnesses     
a. HIV/AIDS     
 Yes 0 0.0 0 0.0 
No 30 100.0 30 100.0 
b. Diabetes     
 Yes 3 10.0 5 16.7 
No 27 90.0 25 83.3 
c. Cancer     
 Yes 0 0.0 0 0.0 
No 30 100.0 30 100.0 
 
            Most of them had 3-6 months chronicity of disease and obtained healthcare resources 
from PHC in both the group. Alcohol/substance abuse habit, co-morbid illnesses of AIDS, 
diabetes and cancer was not similar in both the group. 
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SECTION 4.2: ASSESSMENT AND COMPARISON OF PRE AND THE POST TEST 
LEVEL OF KNOWLEDGE AND ATTITUDE REGARDING PREVENTION OF MDR-
TB AMONG THE EXPERIMENTAL AND CONTROL GROUP 
Table 4.2.1: Frequency and percentage distribution of pre and the post test level of 
knowledge regarding prevention of MDR-TB among experimental and control group             
N=60  
Group 
Level of 
knowledge 
Inadequate 
 
Moderately 
adequate 
(51-74%) 
Adequate 
(75-100%) 
No % No % No % 
 
E
xp
er
im
en
ta
l 
gr
ou
p 
n=
30
 
Pretest 27 90.0 3 10.0 0 0.0 
Posttest 0 0.0 9 30.0 27 70.0 
 
C
on
tr
ol
 
G
ro
up
 
n=
30
 Pretest 26 86.7 4 14.3 0 0.0 
Posttest 23 76.7 7 23.3 0 0.0 
 
           The above table shows that there was no adequate level of knowledge during pre 
test among the experimental group and significant improvement was found regarding 
prevention of MDR-TB. Whereas in the control group no improvement in the level of 
knowledge in both pre and post test.                                                                                                              
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Table 4.2.2: Frequency and percentage distribution of pre and the post test level of 
attitude regarding prevention of MDR-TB among the experimental and control 
group  
                                                                                                                  N=60  
Group 
 
Level of 
attitude 
Unfavourable 
 
Moderately 
favourable 
(51-74%) 
Favourable 
(75-100%) 
No % No % No % 
 
E
xp
er
im
en
ta
l g
ro
up
 
n=
30
 
 
Pretest 
 
26 
 
86.7 
 
4 
 
14.3 
 
0 
 
0.0 
 
Posttest 
 
 
0 
 
0.0 
 
10 
 
    33.3 
 
20 
 
66.7 
 
C
on
tr
ol
 G
ro
up
 
n=
30
 
 
Pretest 
 
25 
 
83.3 
 
5 
 
16.7 
 
0 
 
0.0 
 
Posttest 
 
 
24 
 
80.0 
 
      6 
 
    20.0 
 
0 
 
66.7 
        
           The above table shows that there was no improvement in the level of attitude 
regarding prevention of MDR-TB among the experimental group in the pre test and 
significant changes observed during the post test. There is no improvement in the level of 
attitude among the control group both in the pre and posttest.                                                              
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SECTION 4.3: EFFECTIVENESS OF SELF CARE MODULE ON KNOWLEDGE 
AND ATTITUDE REGARDING PREVENTION OF MDR -TB BETWEEN THE 
EXPERIMENTAL AND CONTROL GROUP  
Table 4.3.1: Comparison of pretest and post test knowledge scores regarding 
prevention of MDR-TB among experimental and control group                   
N=60 
Knowledge 
Pretest Post test 
3DLUHGµW¶YDOXH 
Mean S.D Mean S.D 
 
Experimental  group 
n=30 
 
7.73 
 
1.87 
 
16.23 
 
1.56 
t = 18.02 
p= 0.001, 
S*** 
 
Control group 
n=30 
 
8.26 
 
1.76 
 
9.20 
 
1.71 
t = 1.81 
p = 0.07, 
N.S 
 *** Very high significant at   S** Highly significant at S* Significant at 
S16 QRWVLJQLILFDQW 
 
The above table shows that the comparison between pretest and post test 
knowledge scores regarding prevention of MDR-TB among experimental and control 
group. In the experimental group, the calculated paired µW¶WHVWYDOXHRI shows very 
high significant at   Swhich indicates improvement in the level of knowledge with 
Self Care Module been effective when compared to the control group, which showed no 
significant difference in the paired ¶W¶ test. 
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Table 4.3.2: Comparison of pretest and post test attitude scores regarding 
prevention of MDR-TB among experimental and control group.                                         
N=60 
Attitude 
Pretest Post test 
3DLUHGµW¶YDOXH 
Mean S.D Mean S.D 
Experimental  group 
n=30 
   
 16.20 
 
 
2.46 
 
32.30 
 
3.07 
t = 24.33 
p= 0.001, 
S*** 
Control group 
n=30 
 
16.50 
 
 
 
3.06 
 
17.30 
 
3.22 
t = 1.73 
p = 0.09, 
N.S 
 *** Very high significant at   S** Highly significant at S* Significant at 
S16 QRWVLJQLILFDQW 
 
         The above table shows the comparison of pretest and post test attitude scores 
regarding prevention of MDR-TB among experimental and control group. The calculated 
SDLUHGµW¶ test value was 24.33 shows very high statistical significance at p in the 
experimental group, whereas in the control group shows the non significance. This 
denotes that the Self Care Module was effective to enhance the level of attitude. 
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Table 4.3.3: Comparison of post test level of knowledge scores regarding prevention 
of MDR-TB between experimental and control group.                                
N=60  
Level of knowledge Mean S.D 8QSDLUHGµW¶value 
Experimental 
Group 
16.23 1.56 
t = 16.61 
p =  0.001*** 
Control Group 
9.20 1.71 
*** Very high significant at   S** Highly significant at S* Significant at 
S16 QRWVLJQLILFDQW                     
 
        The above table depicts the comparison of post test level of knowledge scores 
regarding prevention of MDR-TB between experimental and control group. Where the 
calculated unpaired µW¶ YDOXHRI W  VKRZVKLJK VWDWLVWLFDO VLJQLILFDQFH DW S. 
This shows that Self Care Module on MDR-TB was effective in improving the level of 
knowledge 
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Table 4.3.4: Comparison of post test level of attitude scores regarding prevention of 
MDR-TB between experimental and control group.                                           
N=60                        
Level of attitude Mean S.D 8QSDLUHGµW¶YDOXH 
Experimental Group 32.30 3.07            t = 18.42 
p =  0.001*** Control Group 17.30 3.22 
*** Very high significant at   S** Highly significant at S* Significant at 
S16 QRWVLJQLILFDQW                     
       
       The above table shows the comparison of post test level of attitude scores 
regarding prevention of MDR-TB between experimental and control group. The 
calculated unpaired µW¶ value of t= 18.42 shows high statistical significance at p<0.001 
indicated that Self Care Module was effective in improving the level of attitude. 
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SECTION 4.4: CORRELATION OF THE POST TEST LEVEL OF 
KNOWLEDGE WITH ATTITUDE SCORE REGARDING PREVENTION OF 
MDR-TB IN THE EXPERIMENTAL GROUP. 
Table 4.4.1: Correlation of the post test level of knowledge with attitude score 
regarding prevention of MDR-TB in the experimental group. 
N=30 
Variable Mean S.D µU¶YDOXH 
Knowledge 6.23 1.56 r = 0.52 
       p = 0.001*** Attitude 32.30 3.07 
*** Very high significant at   S** Highly significant at S* Significant at 
S16 QRWVLJQLILFDQW                     
 
         The above table shows the correlation of the post test level of knowledge with 
attitude score regarding prevention of MDR-TB in the experimental group depicts that 
the µU¶YDOXH of 0.52 which reveals there was a significant, moderate, positive correlation 
between the knowledge and attitude of TB patients. It means that when level of 
knowledge increases, their level of attitude also increases. 
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Table 4.4.2: Correlation of the post test level of knowledge with attitude score 
regarding prevention of MDR-TB in the control group.  
                                                 N=30 
Variable Mean S.D µU¶YDOXH 
Knowledge 16.50 3.06          r = 0.19 
         p =  0.32 
           N.S 
Attitude 17.30 3.22 
*** Very high significant at   S** Highly significant at S* Significant at 
S16 QRWVLJQLILFDQW                     
         
The above table shows the correlation of the post test level of knowledge with 
attitude score regarding prevention of MDR-TB in the control group ZLWK µU¶ YDOXH of 
0.19 which reveals poor positive correlation. It means knowledge and attitude had no 
improvement. 
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SECTION 4.5:  ASSOCIATION OF SELECTED DEMOGRAPHIC VARIABLES 
WITH THE MEAN DIFFERED LEVEL OF KNOWLEDGE AND ATTITUDE 
REGARDING PREVENTION OF MDR-TB IN THE EXPERIMENTAL GROUP 
 Table 4.5.1: Association of selected demographic variables with the mean differed 
level of knowledge gain score regarding prevention of MDR-TB in the experimental 
group          
                                                                                                                                 N=30 
S.No Demographic Variables 
Level of knowledge gain 
Total 
Chi-
square 
test 
Below 
DYHUDJH 
Above 
average(>8.50) 
N % n % 
1. Age 
(in years) 
20 -29  
7 77.8 2 22.2 9 
F2=9.89 
p=0.05* 
  30 -39  4 66.7 2 33.3 6 
  40 -49  3 42.8 4 57.2 7 
  50 -59  1 20.0 4 80.0 5 
  > 60  0 0.0 3 100.0 3 
2. Gender Male 5 31.2 11 68.8 16 F2=4.82 
p=0.03*   Female 10 71.4 4 28.6 14 
3. Educational  
status 
Non-Literate 4 80.0 1 20.0 5 
F2=12.17 
p=0.05* 
  Primary 
school 
certificate 
6 85.7 1 14.3 7 
  Middle school 
certificate 
4 50.0 4 50.0 8 
  Higher school 
certificate 
1 20.0 4 80.0 5 
  Intermediate 
or post high 
school dip 
0 0.0 2 100.0 2 
  Graduate or 
Postgraduate 
0 0.0 3 100.0 3 
 
       The above table shows the association of selected demographic variables with the 
mean differed level of knowledge gains core in the experimental group such as age, 
gender and educational status had moderate statistical significance which was confirmed 
using ANOVA gain score with chi-square test 
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Table 4.5.2: Association of selected demographic variables with the mean differed 
level of attitude gain score regarding prevention of MDR-TB in the experimental 
group 
                                                                                                                    N=30 
S.No. Demographic Variables 
Level of attitude gain score 
Total 
Chi 
square 
test 
Below 
DYHUDJH 
Above 
average(>16.10) 
n % n % 
1. Age 
(in years) 
20 -29 6 66.7 3 33.3 9 
F2=9.65 
p=0.05* 
  30 -39 5 83.3 1 16.7 6 
  40 -49 2 28.6 5 71.4 7 
  50 -59 2 40.0 3 60.0 5 
  > 60 0 0.0 3 100.0 3 
2. Gender Male 5 31.2 11 68.8 16 F2=4.82 
p=0.03*   Female 10 71.4 4 28.6 14 
3. Educational 
status 
Non-Literate 5 100.0 0 0.0 5 
F2=13.08 
p=0.05* 
 
  Primary 
school 
certificate 
4 66. 2 33.3 7 
  Middle 
school 
certificate 
4 50.0 4 50.0 8 
  Higher 
school 
certificate 
1 20.0 4 80.0 5 
  Intermediate 
or post high 
school dip 
0 0.0 2 100.0 2 
  Graduate or 
Postgraduate 
0 0.0 3 100.0 3 
 
             The above table shows that the selected demographic variables such as age, 
gender and educational status had moderate statistical significance with the mean 
differed level of attitude in the experimental group at p< 0.5 level. 
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DISCUSSION 
 
This chapter discusses about the analytical findings of the study based on the 
objectives. It is a quasi experimental study to assess the effectiveness of Self Care 
Module on knowledge and attitude regarding prevention of Multidrug-Resistant 
Tuberculosis (MDR-TB) among Tuberculosis (TB) patients at selected setting, Chennai. 
 
5.1 The findings of the demographic variables of the Tuberculosis patients in the 
experimental and control group 
      The demographic variables of the Tuberculosis patients considered in this study 
was age in years, gender, religion, marital status, educational status, occupation, family 
income, type of family, area of residence, transmission of TB, health care resources, 
personal habits and co-morbid illness. 
 
      In the experimental group, most common was in the age group of 20-29 years, 
completed middle school certificate with unemployment and in the control group many 
were under 30-39 years completed primary school certificate and unskilled worker. 
 
     In both the group most of the patients were males and Hindu earns Rs.1803-5386, 
by belonged to nuclear family, resides in a semi-urban area with the transmission of TB 
was  uncertain, 3-6 months chronicity of disease and obtained resources from PHC. 
Similarly in both the group, alcohol/substance abuse habit was similarly equal and co-
morbid illnesses of AIDS, diabetes and cancer was not significant in both.      
 
      Indian researcher with evidence Atre SR (2011) suggested that certain data had 
been the contributing factor for developing MDR-TB; they are age group, education, 
occupation, history of smoking and Type 2 diabetes. Researcher Issakidis (2010) 
conducted a study and understood that TB with HIV co-infection patients may develop 
MDR-TB due to family caregivers being transverse to maintain mental and physical 
health of those patients by leading into treatment adherence.     
 
     To represent various aspects of the study, the investigator had adopted the 
concepts of Evelyn Adam Interpersonal Relationship Model.   
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5.2 The first objective was to assess and compare the pre and post level of 
knowledge and attitude regarding prevention of MDR-TB among experimental and 
control group 
     There was no adequate level of knowledge among TB patients during pre test 
whereas in the post test after administration of SCM had significant increase regarding 
the prevention of MDR-TB among the experimental group 
 
        But there is no improvement in the level of knowledge and attitude among the 
control group in pre and the post test. 
 
      Researchers Bhatt G, Vyas S, Trivedil K (2012) conducted a cross sectional 
study to assess the socio demographic profile, housing environment, health-seeking 
behaviour, present and past history regarding treatment of MDR-TB was carried out 
through personal interviews using pre-designed, pre-tested proforma and the findings 
revealed that most of the patients perceived some degree of improvement in their health 
based on their factors following the treatment. 
 
5.3 The second objective was to assess the effectiveness of Self Care Module on 
knowledge and attitude regarding prevention of MDR-TB between the 
experimental and control group 
       Comparison of pretest and post test knowledge scores regarding prevention of 
MDR-TB among experimental and control group, the calculated paired µW¶ test value of 
18.02 and 24.33 respectively that shows very high statistical significance at p 
among experimental group and the calculated  unSDLUHG µW¶ test value of 1.81and 1.73 
indicates no statistical significance among control  group. 
 
      Comparison of post test knowledge and attitude scores regarding prevention of 
MDR-TB between experimental and control group, the XQSDLUHGµW¶ value 16.61and 18.42 
shows high statistical significance at p<0.001 level.  
 
      The above findings show that Self Care Module was effective in improving the 
level of knowledge and attitude regarding prevention of MDR-TB in the experimental 
than the control group. 
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       Hence the null hypothesis NH1 stated earlier that ³there is no significant 
difference in the post level of knowledge and attitude regarding prevention of 
MDR-7%EHWZHHQWKHH[SHULPHQWDODQGFRQWUROJURXSDWSOHYHO´ZDVUHMHFWHG
in experimental group and accepted in control group. 
 
5.4 The third objective was to correlate the post test level of knowledge with 
attitude score regarding prevention of MDR-TB in the experimental and control 
group 
         Correlation between the post test level of knowledge with attitude score regarding 
prevention of MDR-TB in the experimental group was calculated using Karl Pearson 
FRUUHODWLRQFRHIILFLHQWZLWK µU¶YDOXH of 0.52 which reveals that there was a significant 
moderate positive correlation between the level of knowledge and attitude among  TB 
patient so knowledge increases their level of attitude also increases  
 
         Correlation between the post test level of knowledge with attitude score regarding 
prevention of MDR-TB in the control group calculated and found the µU¶YDOXH as 0.19 
which reveals poor positive correlation between the knowledge and attitude among TB 
patients. 
 
         Hence the null hypothesis NH2 states that ³there is no significant relationship 
between the post level of knowledge and attitude regarding prevention of MDR-TB 
LQWKHH[SHULPHQWDODQGFRQWUROJURXSDWSOHYHO´UHMHFWHGH[SHULPHQWDOJURXS
and accepted in control group 
 
5.5 Association of selected demographic variables with the mean differed level of 
knowledge and attitude score regarding prevention of MDR-TB in the experimental 
group 
        The selected demographic variables like age, gender and educational status had 
moderate significance with the mean differed level of knowledge and attitude than other 
variables in the experimental group.        
         Hence the null hypothesis NH3 stated earlier that ³there is no significant 
association of selected demographic variables with the mean difference level of 
knowledge and attitude regarding prevention of MDR-TB in the experimental and 
control group DWSOHYHO´ was rejected for age, gender and educational status 
in the experimental group and accepted for other selected demographic variables.  
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SUMMARY, CONCLUSION, IMPLICATIONS, 
RECOMMENDATIONS AND LIMITATIONS 
         
This chapter represents the summary, conclusion, implications, recommendations 
and limitations of the study. 
 
6.1 SUMMARY 
            Multidrug- Resistant Tuberculosis (MDR-TB) is a major health problem that 
threatens TB patients as it is caused by bacteria that are resistant to first line anti-TB 
drugs such as Isoniazid (INH) and Rifampicin (RMP). In 2013, about 5% of TB cases 
were diagnosed to have MDR-TB. Most of the acquired MDR-TB is due to inappropriate 
treatment, improper prescription of treatment, non-compliance of treatment and scarcity 
of medicines. There are various methods to prevent MDR-TB such as rapid diagnosis 
and treatment of TB, completion of treatment, identifying and diagnosing HIV/AIDS 
patients as early as possible and identifying the causes that contracts TB. Thereby 
prevention can inhibit the prevalence of MDR-TB. 
 
            The purpose of the study was to assess the effectiveness of Self Care Module on 
knowledge and attitude regarding prevention of MDR-TB among TB patients. The 
findings reveal that there was a significant difference in the pretest and posttest 
knowledge and attitude regarding prevention of MDR-TB among TB patients. 
 
The objectives of the study were 
1. To assess and compare the pre and post test level of knowledge and attitude 
regarding prevention of MDR-TB among the experimental and control group. 
2. To assess the effectiveness Self Care Module on knowledge and attitude 
regarding prevention of MDR-TB between the experimental and control group. 
3. To correlate the post test level of knowledge with attitude score regarding 
prevention of MDR-TB in the experimental and control group. 
4. To associate the selected demographic variables with the mean differed level of 
knowledge and attitude regarding prevention of MDR-TB in the experimental 
group. 
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The study was based on the assumptions that 
1. Self Care Module may improve the knowledge and provide favourable attitude 
among Tuberculosis patients. 
2. The Tuberculosis patients may have some knowledge and attitude on prevention 
of MDR-TB. 
 
The null hypotheses formulated were 
NH1:  There is no significant difference in the post test level of knowledge and attitude 
regarding prevention of MDR-TB between the experimental and control group at 
p<0.05 level. 
NH2:  There is no significant relationship between the post test level of knowledge and 
attitude regarding prevention of MDR-TB in the experimental and control group 
at p<0.05 level. 
NH3:  There is no significant association of selected demographic variables with the 
mean difference level of knowledge and attitude regarding prevention of MDR-
TB in the experimental group at p<0.05 level. 
 
             7KH UHYLHZ RI OLWHUDWXUH SUDFWLFDO H[SHULHQFH DQG H[SHUW¶V JXLGDQFH SURYLGHG
strong support for the study. The reviews also developed a basis for conceptual 
framework, aided to design the methodology and formulation of the tool. 
 
             To represent various aspects of the study, the investigator had adopted the 
concepts of Evelyn Adam Interpersonal Relationship Model. 
 
              The investigator had used a quasi experimental, equivalent control group design 
to assess the effectiveness of Self Care Module on knowledge and attitude regarding 
prevention of Multidrug-Resistant Tuberculosis (MDR-TB) among 60 Tuberculosis (TB) 
patients by using non probability purposive sampling technique. 
 
              The tool constructed for this study has two parts. The first part is data collection 
tool with three sections (demographic variables , assessment of knowledge and attitude) 
and  the second part is intervention tool ( Education , Video show and Pictorial booklet) 
.The collected data was analyzed and interpreted based on the objectives and null 
hypotheses by using descriptive and inferential statistics. 
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The major findings of the study revealed that, 
       The analysis regarding the post test level of knowledge indicates70% of the TB 
patients had adequate knowledge and 66.7% had favourable attitude regarding 
prevention of MDR-TB in the experimental group. 
 
       The correlation between the post test level of knowledge with attitude score 
regarding prevention of MDR-TB in the experimental group was calculated using Karl 
3HDUVRQFRUUHODWLRQFRHIILFLHQWZLWKµU¶YDOXH of 0.52 which reveals significant, moderate, 
positive correlation. It means when knowledge increases their attitude also increases. 
 
        In the experimental group the TB patients showed a significant association with 
the demographic variables such as age, gender and educational status and gained 
knowledge and attitude than others. 
 
        This clearly indicates that Self Care Module had effectiveness in improving the 
knowledge and attitude regarding prevention of MDR-TB among TB patients. 
 
6.2 CONCLUSION 
        The particular study was conducted to assess the effectiveness of Self Care 
Module on knowledge and attitude regarding prevention of MDR-TB among 
Tuberculosis (TB) patients. The findings of the study revealed that there was a 
significant difference in the pre test and post test level of knowledge and attitude 
regarding prevention of MDR-TB among Tuberculosis (TB) patients. Therefore the Self 
Care Module was found effective in improving the knowledge and attitude regarding 
prevention of MDR-TB. 
 
6.3 IMPLICATIONS 
        The investigator has derived the following implications from the study, which is 
of vital concern in the field of nursing practice, nursing education, nursing administration 
and nursing research. 
 
6.3.1 Nursing Practice 
1. The nurse plays a essential role in building the knowledge and attitude on 
preventive aspects. 
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2. The intervention is cost effective, reliable and can be incorporated by the nurses 
in all the specialized hospitals in preventing MDR-TB. 
3. The nurse should understand the need of motivating the caregivers to follow the 
booklet intervention for the promotion of the patients life. 
4. The intervention module can be implemented in OPD and IPD department of 
various hospitals. 
 
6.3.2 Nursing Education 
1. The study enables the nurse educator to incorporate the findings in nursing 
curriculum with evidence based practice. 
2. The nurses can acquire adequate knowledge by conducting continuing nursing 
education. 
 
6.3.3 Nursing Administration 
1. The nurse administrator can organize the training programme for the caregivers 
and other patients with TB illness for reducing the disease burden. 
2. The nurse administrator can encourage the replication of the study with large 
samples. 
 
6.3.4 Nursing Research 
1. The findings of the study can be disseminated through conferences, seminars and 
by publishing in journals. 
2. Nurse researcher should encourage the staff nurse to implement the research 
findings in the daily care of similar patients and bring out more scope to promote 
the health of the patients. 
 
 6.4 RECOMMENDATIONS 
1. 7KH LQYHVWLJDWRU UHFRPPHQGV WR JLYH WKHPRGXOH WR YDULRXV 7% FHQWUH1*2¶V 
(Reach) /hospital through ICCR and Director of District TB centre 
2. Similar study will be replicated on large sample to increase the validity and 
generalizability of the findings. 
3. 7KHVLPLODUVWXG\ZLOOEHLPSOHPHQWHGWRWKH7XEHUFXORVLVSDWLHQW¶VFDUHJLYHUVWR
promote the quality of life. 
4. The further study will be done for enhancing the knowledge on XDR-TB. 
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6.5 LIMITATIONS 
1. The investigator found difficulty in obtaining the setting permission for the study 
2. The investigator found difficulty to get nursing intervention related reviews both 
Indian as well as International. 
 
6.6 PLAN FOR RESEARCH UTILIZATION 
1. Self Care Module was planned to utilize in Omayal Achi Community health 
centre 
2. The booklet is being used currently in District Tuberculosis Centre for the 
uncovered Tuberculosis patients by the healthcare professionals as recommended 
by the Director.  
3. The Director of the centre planned to recommend the booklet education to other 
TB centre patients for improving their knowledge on prevention of MDR-TB  
 
6.7 PLAN FOR RESEARCH DISSEMINATION 
1. Scientific paper presentation in Conferences of various Colleges in Chennai. 
2. Plan to publish the study in Journal of Nursing Research of Omayal Achi College 
of Nursing , Trained Nurses Association of India  and Health Action journals, and 
British Journal of Nursing within 6 months period of time 
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gFjp - M 
totikf;fg;gl;l ngl;o ml;ltiz 
1. fhrneha; cUthf fhuzk; vd;d? 
1. bfhRf;fs; 
2. Ez;Qaphpdhy;  
3. fhw;W khRg;ghL 
4. jz;zPh; khRg;ghL 
 
2. fhrneha; kw;Wk;  gykUe;J vjph;g;g[ fhrneha;f;Fk; cs;s ntWghLfs; vd;d? 
 1. ve;j ,izg;g[k; ,y;iy 
 2. gf;ftpist[ 
 3. Mgj;Jf; fhuzpfs;  
 4. bgUk;tpist[ 
 
3. gykUe;J  vjph;g;g[ fhrneha; vd;why; vd;d? 
 1. Cl;lr;rj;J Fiwt[ fhrneha; 
 2. mjpf mst[ kUe;J cl;bfhs;Stjhy; 
 3. rhpahd Kiwapy; kUe;J cl;bfhs;shjjhy;   
 4. xt;thikahy; Vw;gLk; fhrneha; 
 
4. gy kUe;J vjph;g;g[ fhrnehia vg;go tifg;gLj;jyhk;? 
 1. VnjDk; xU kUe;J vjph;g;g[ 
 2. Kjw;f;fl;l kUe;J vjph;g;g[ 
 3. 2-Mk; fl;l kUe;J vjph;g;g[ 
 4. ,uz;ow;f;Fk; nkw;g;gl;l kUe;J vjph;g;g[ 
 
5. gy kUe;J vjph;g;g[ fhrneha; ve;j ehl;od; bgUk;Rikahf fUjg;gLfpwJ. 
 1. rPdh 
 2. g';fshnjrk; 
 3. ,e;jpah 
 4. mbkhpf;fh 
 
 
6. gy kUe;J vjph;g;g[ fhrnehahy; Vw;gLk; kf;fspd; ,wg;g[ tpfpjk;  xU tUlj;jpw;F  
,e;jpahtpy;   
1. 50/000f;Fk; fPH; 
2. 50/000 - 1 yl;rk; 
3. fpl;ljl;l 2 yl;rk; 
4. 5 yl;rj;jpw;F nky; 
 
7.  gy kUe;J vjph;g;g[ fhrnehapd; kpf Kf;fpa Mgj;Jf;fhuzpfs; ahh;? 
 1. va;l;!; nehahspfs;  
 2.5 tajpw;Fl;gl;l FHe;ijfs; 
 3. guk;giu neha; cilnahh; 
 4. fh;g;gpzpfs; 
 
8. va;l;!; neha; cs;nshh;f;F mjpf mstpy; gy kUe;J vjph;g;g[  fhrneha;  
    Vw;gLtjw;fhd fhuzk; vd;d? 
1. vjph;g;g[ rf;jp FiwghL 
2. ,d;Rypd; FiwghL 
3. Cl;lr;rj;J FiwghL 
4. Mwpahik 
 
9.thH;ehspy; va;l;!; nehahspfSf;F fhrneha; Vw;gLtjw;fhd Mgj;J  
    tpfpjk; 
1. 50% 
2. 10% 
3. 100% 
4. 2% 
 
10. gykUe;J vjph;g;g[ fhrneha; cz;lhf fhuzk; ahJ? 
 1. kUj;Jt fl;lj;ij ,ilapUtjhy;  
 2. nehahspapd; kUj;Jt fz;fhzpg;g[ gw;whf;Fiw 
 3. jLg;g[ kUe;J ,lhjjhy;  
 4. tpHpg;g[zh;r;rpapd;ik 
 
11.  kUe;J vjph;g;g[ fhrnehahy; Vw;gLtJ  
 1. _l;Ltyp 
 2. k";rs; fhkhiy 
 3. fhJnfshik 
 4. ghh;it Fiwt[ 
 
12. kUe;J vjph;g;g[ fhrneha;f;fhd ghpnrhjid Kiw 
 1. kUe;J <h;g;g[ ghpnrhjid 
 2. vf;!;nu 
 3. rp.o.!;nfd; 
 4. mwpFwpfs; _yk; 
 
13.  gy kUe;J vjph;g;g[ fhrnehapd; rpfpr;ir fhy mst[ 
 1. 3 khjk; tiu 
 2. 6 khjk; tiu 
 3. 2 tUlk; tiu 
 4. 3 tUlj;jpw;F nky; 
 
14. gy kUe;J vjph;g;g[ fhrneha; rpfpr;ir Kiw vj;jid fl;lkhf gpd;gw;w  
     ntz;Lk;? 
1. 2 fl;lk; 
2. 1 fl;lk; 
3. 3 fl;lk; 
4. 5 fl;lk; 
 
15. gpd;tWgdtw;Ws; rpfpr;irapd; nghJ nehahspfsplk; Kf;fpakhf  
     fz;fhzpf;f glntz;oaJ. 
1. mjpf vilFiwt[ 
2. g[jpajhf Vw;gLk; jokd;fs; 
3. tpah;it mjpfhpg;gJ / FiwtJ 
4. bjhlh;e;J kaf;fk; Vw;gLtJ 
 
 
16. neha; gut[jiy fl;LgLj;Jtjw;fhd ey;y gHf;f tHf;fk; 
 1. Rfhjhukhd Rthr Kiw 
 2. jLg;g{rp ,LtJ 
 3. Rw;Wg;g[w Rfhjhuk; 
 4. Mnuhf;fpakhd czt[ 
 
17. ,e;nehahspfs; vd;d tifahd czt[ mjpfmstpy; cl;bfhs;s  
     ntz;Lk;? 
1. vy;yh tif czt[ 
2. g[ujr;rj;J czt[ 
3. bfhGg;g[r;rj;J czt[ 
4. khkpr tif czt[ 
 
18. fhrneha[s;s rh;f;fiu nehahspfs; gpd;gw;w ntz;oa  
     Kd;bdr;rhpf;iffs; vJ? 
1. jLg;g{rp 
2. ngh\hf;;fhd czt[ 
3. rhptpfpj ,uj;jrh;f;fiu mst[ 
4. tHf;fkhd clw;ghpnrhjid 
 
19. bghUj;j kw;w rpfpr;irapdhy; Vw;gLk; gpd;tpist[fs; 
1. ,wg;g[ 
2. rpWePufr; braypHg;g[ 
3. EiuaPuy; g[w;Wneha; 
4. rPH;g;gpoj;jy; 
 
20. fhrneha; / gy neha; kUe;J vjph;g;g[ fhrneha;f;fhd _lek;gpf;if   vd;d? 
1. Fzg;gLj;j KoahJ 
2. jPa Mtpahy; Vw;gLtJ 
3. guk;giw neha; 
4. ,wg;g[ cz;lhf;Fk; 
 
